Profile: Stryker Corp (SYK)
26 Sep 2016
Stryker Corporation (Stryker), incorporated on February 20, 1946, is a medical technology company. The Company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Company offers its products to doctors, hospitals and other healthcare facilities. The Company's products include implants used in joint replacement and trauma surgeries; surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment, and neurosurgical, neurovascular and spinal devices, as well as other medical device products used in a range of medical specialties. The Company's products are sold in approximately 100 countries through the Company-owned sales subsidiaries and branches, as well as third-party dealers and distributors. The Company offers a 1588 advanced imaging modalities (AIM) platform, which is designed for optimum visualization across surgical specialties.
The Company's Orthopaedics segment products consist of implants used in hip and knee joint replacements, trauma and surgeries. The Company's orthopedic products include hip replacement systems, knee replacement systems, shoulder and elbow systems, bone cement, sports medicine, joint preservation, bone substitutes, soft tissue repair and computer assisted surgery.
The Company competes with Zimmer Biomet Holdings, Inc., DePuy Synthes and Smith & Nephew plc.
The Company's MedSurg segment products consist of surgical equipment and surgical navigation systems (Instruments); endoscopic and communications systems (Endoscopy); patient handling and emergency medical equipment (Medical), and reprocessed and remanufactured medical devices (Sustainability), as well as other medical device products used in a range of medical specialties. The Company's surgical equipment includes blood products, cement mixers, pulsed irrigation, waste management, pressure monitors and safety-sponge system.
The Company competes with Medtronic plc, CONMED Corporation, Smith & Nephew Endoscopy, Arthrex, Inc., Karl Storz GmbH & Co., Olympus Optical Co. Ltd, Steris and Hill-Rom Holdings, Inc.
Neurotechnology and Spine
The Company's Neurotechnology and Spine segment products consist of both neurosurgical and neurovascular devices. The Company's neurotechnology offering includes products used for minimally invasive endovascular techniques; products for brain and open skull base surgical procedures; orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. The Company also develops, manufactures and sells spinal implant products, including cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies.
The Company competes with Medtronic, Terumo Corporation, Penumbra, Inc., DePuy Synthes, Nuvasive, Inc. and Globus Medical, Inc.
2825 Airview Blvd
PORTAGE MI 49002-1802
Company Web Links
- BRIEF-Stryker announces agreement to acquire the assets of Instratek
- Lower court to decide on boosted damages for Stryker Corp
- BRIEF-Stryker entered credit agreement with various lenders - SEC filing
- BRIEF-Stryker declares a $0.38 per share quarterly dividend
- BRIEF-Stryker sees Q3 adjusted earnings per share $1.33 to $1.38